Medical network - on September 15, Chinese medical data and artificial intelligence industry practice BBS will be held on Saturday, it is understood that when will issue the first domestic "2017 China + medical artificial intelligence industry research report. The personage inside course of study thinks, artificial intelligence, the efficiency and accuracy of clinical diagnosis were significantly higher than the human doctor, as the aging population and labor costs rise in China, the future of artificial intelligence in the field of medical diagnosis is expected to accelerate penetration process.
September 16-17, 2017 China medical big data and artificial intelligence industry practice BBS is held in wuhan. BBS will through the data analysis, case anatomy, evolution from industrial policy guidance, technical cooperation, business model, industry such as Angle, research of medical data and the artificial intelligence enterprise, statistical data analysis, explanation industry development trend.
Health care and health care are now in the digital inflection point, according to senior industry insiders. The medical industry showed explosive growth in data input and data accumulation, with 60% and 50% of consumers willing to share health data with Google and apple. In terms of professional data, the penetration rate of electronic cases in the United States reached 87%, and the accumulation of genetic data increased the genetic knowledge by 19 times. Global health data is growing at a 48% annual rate. On the one hand, the growth of data has shortened the innovation cycle of medical research, accelerated the drug clinical trial cycle, and improved the accuracy of diagnosis and the degree of precision of treatment.
Medical treatment combined with artificial intelligence is the key to "algorithm + data", the depth of the development of the learning algorithm is already relatively mature, the "quantity" and "quality" of medical data is hindering the development of the artificial intelligence application in the medical industry. Orient securities believes that as global healthcare enters a digital inflection point, the rapid growth in the amount of healthy data authorized by customers will provide a prerequisite for industry development.
The application of artificial intelligence in medical industry includes: preclinical disease prevention and health management; Auxiliary diagnosis in diagnosis, medical image processing; Postdiagnosis of virtual health care assistant, slow disease management. Other areas include drug development, health care, and so on. At present, relatively mature fields include "intelligent diagnosis" and "medical image recognition".
On the subject of investment, Orient securities suggests a three-line grasp, one is to apply localized foreign companies, such as chuang medical benefits; The second is to cut into the segments (such as medical image recognition), the company with application scenarios and the introduction of artificial intelligence technology, such as wandong medical care; Three is the intelligent control fee system manufacturer with medical big data operation, such as wei ning health.
"The efficiency and accuracy of artificial intelligence medical diagnosis are much higher than that of human doctors, and the prospect of 'cognitive computing + big data + medical' is very promising. AI product diminishing marginal cost significantly, and with increased usage performance are improved greatly, as the aging population and labor costs rise in China, the AI is expected to accelerate penetration process in the field of medical diagnosis." Great Wall securities believes that the prospect of intelligent medical diagnosis industry is broad, and it is recommended to pay attention to the underlying floor targets such as: yi lianzhong (medical big data), creative doctor hui (cooperation with IBMWaston), etc.; Application layer targets such as: dispatch of hkust fly (voice communication in the diagnosis of class), lang ma information (on-line diagnosis), dean diagnosis (intelligent diagnosis instrument), Wright (monitoring instrument), happy heart health (health management).
|
